Evaluation of Circulating Tumor DNA as a Theranostic Marker in the Management of Glioblastomas. (Q66046385)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Evaluation of Circulating Tumor DNA as a Theranostic Marker in the Management of Glioblastomas. |
clinical trial |
Statements
Bi-GLAM (English)
0 references
Evaluation of Circulating Tumor DNA as a Theranostic Marker in the Management of Glioblastomas. (English)
0 references
9 March 2016
0 references
8 March 2020
0 references
100
0 references
18 year
0 references